VIRCLIA®
Indirect chemiluminescent immunoassay (CLIA) in monotest format to test antibodies against infectious diseases in human serum/plasma samples. VirClia® offers the ultimate solution for the automation ...
Founded in 1991, Vircell is a biotechnology company specialized in the development and production of ready-to-use reagents for the diagnosis of infectious diseases in humans by different techniques – ranging from the traditional cell culture to the most innovating developments in the field of molecular biology. Vircell has been a successful market player worldwide, distributing its products in over 80 countries across the five continents.
Indirect chemiluminescent immunoassay (CLIA) in monotest format to test antibodies against infectious diseases in human serum/plasma samples. VirClia® offers the ultimate solution for the automation ...
VirClia ® Plus provides high throughput automation of immunoassay-based infectious disease testing and brings flexibility, easy-to-use robotics and autonomy to your laboratory.
Founded in 1991, Vircell is a biotechnology company specialized in the development and production of ready-to-use reagents for the diagnosis of infectious diseases in humans by different techniques – ranging from the traditional cell culture to the most innovating developments in the field of molecular biology. Vircell has been a successful market player worldwide, distributing its products in over 80 countries across the five continents.